Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The rationale for continuous, hyperfractionated, accelerated radiotherapy (CHART).

S Dische1, M I Saunders

  • 1Regional Center for Radiotherapy and Oncology, Mount Vernon Hospital, Northwood, Middlesex, England.

International Journal of Radiation Oncology, Biology, Physics
|November 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

To restore coastal marine areas, we need to work across multiple habitats simultaneously.

Proceedings of the National Academy of Sciences of the United States of America·2023
Same author

Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO).

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

Impact of sea-level rise and coral mortality on the wave dynamics and wave forces on barrier reefs.

Marine pollution bulletin·2014
Same author

Phase Ib trial of radiotherapy in combination with combretastatin-A4-phosphate in patients with non-small-cell lung cancer, prostate adenocarcinoma, and squamous cell carcinoma of the head and neck.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

Adaptive 18fluoro-2-deoxyglucose positron emission tomography/computed tomography-based target volume delineation in radiotherapy planning of head and neck cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2010
Same author

Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans.

British journal of cancer·2009
Same journal

Liver tumor motion and reconstructed doses in a clinical trial of respiratory gated proton therapy for hepatocellular carcinoma.

International journal of radiation oncology, biology, physics·2026
Same journal

Local sinonasal and regional nodal effects of lymph node irradiation in a pilot study of dogs with naturally occurring sinonasal tumors.

International journal of radiation oncology, biology, physics·2026
Same journal

Cross-Institutional Validation of a novel LLM-Based Cardiac Event Extraction framework from Electronic Health Records.

International journal of radiation oncology, biology, physics·2026
Same journal

Cardiac Substructure Dosimetry and Major Adverse Cardiac Events After Breast Radiotherapy: A 12-Year Cohort Study with NTCP Modeling.

International journal of radiation oncology, biology, physics·2026
Same journal

Predictors of Medical Debt Sent to Collections after Radiotherapy.

International journal of radiation oncology, biology, physics·2026
Same journal

External Beam Radiotherapy Primes PDL1-Targeted Radionuclide Therapy in Preclinical Colorectal Cancer Model.

International journal of radiation oncology, biology, physics·2026
See all related articles

Continuous, hyperfractionated, accelerated radiotherapy (CHART) shows improved results for advanced head and neck and bronchial carcinomas. Further multi-center trials are planned to confirm these promising radiotherapy findings.

Area of Science:

  • Radiation Oncology
  • Clinical Oncology
  • Radiobiology

Background:

  • Radiotherapy is a cornerstone of cancer treatment.
  • Optimizing radiotherapy delivery is crucial for improving patient outcomes.
  • Continuous, hyperfractionated, accelerated radiotherapy (CHART) was developed based on radiobiological principles.

Purpose of the Study:

  • To evaluate the efficacy of Continuous, hyperfractionated, accelerated radiotherapy (CHART) in a pilot study.
  • To assess the impact of CHART on clinical radiotherapy outcomes.
  • To identify patient groups that may benefit most from CHART.

Main Methods:

  • A pilot study involving 210 patients was conducted.
  • The study focused on patients with advanced head and neck and bronchial carcinomas.

Related Experiment Videos

  • Results were compared with previously treated cases.

    • Main Results:

    • Improved clinical outcomes were observed in patients treated with CHART.
    • Positive results were noted in both advanced head and neck and bronchial carcinoma groups.
    • The pilot study provides evidence supporting the effectiveness of CHART.

    Conclusions:

    • Continuous, hyperfractionated, accelerated radiotherapy (CHART) demonstrates potential for improving cancer treatment.
    • Further investigation through multi-center randomized controlled trials is warranted.
    • CHART represents a promising advancement in clinical radiotherapy.